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Abstract: Therapeutics designed to increase synaptic neurotransmitter levels by inhibiting neurotransmitter sodium sym-
porters (NSSs) classify a strategic approach to treat brain disorders such as depression or epilepsy, however, the critical 
elementary steps that couple downhill flux of sodium to uphill transport of neurotransmitter are not distinguished as yet. 
Here we present modelling of NSS member neuronal GAT1 with the substrate -aminobutyric acid (GABA), the major 
inhibitory neurotransmitter. GABA binding is simulated with the occluded conformation of GAT1 homodimer in an ex-
plicit lipid/water environment. Simulations performed in the 1-10 ns range of time elucidated persistent formation of half-
extended minor and H-bridged major GABA conformations, referred to as binding and traverse conformations, respec-
tively. The traverse GABA conformation was further stabilized by GAT1-bound Na+(1). We also observed Na+(1) trans-
location to GAT1-bound Cl- as well as the appearance of water molecules at GABA and GAT1-bound Na+(2), conjectur-
ing causality. Scaling dynamics suggest that the traverse GABA conformation may be valid for developing substrate in-
hibitors with high efficacy. The potential for this finding is significant with impact not only in pharmacology but wherever 
understanding of the mechanism of neurotransmitter uptake is valuable. 
Keywords: Binding and traverse conformation, neurotransmitter sodium symporter family, neuronal GABA symporter sub-
type, sodium symport. 
INTRODUCTION  
Cellular uptake of a large variety of essential amino ac-
ids, biogenic amines, related nutrients and osmolytes against 
their concentration gradients in cells is facilitated by Na+ ion 
symporters coupling entropy increase to uphill solute trans-
location on the expense of transmembrane electrochemical 
gradient [1]. Uptake of inhibitory neurotransmitter amino 
acids gamma-aminobutyric acid (GABA) and glycine as well 
as monoamine neurotransmitters serotonin, dopamine and 
norepinephrine is regulated by the SLC6 family subclass 
neurotransmitter sodium symporters (NSSs) that are also 
important targets for central nervous system therapeutics and 
illicit drugs. 
A basic problem in understanding the mechanism of 
NSSs-mediated cellular uptake is how uphill neurotransmit-
ter translocation is spatially and temporally linked to the 
downhill passage of Na+ ions. In this paper we shall there-
fore investigate events evoked by substrate binding and the 
role for Na+ ions, taking the major human GABA transporter 
subtype (hGAT1) as an example. Molecular modelling of 
hGAT1 subtype and simulation of the GABA/Na+ symport 
(co-transport) mechanisms has become possible by the high-
resolution structure elucidation of the outward open, oc-
cluded [2] and inward open [3] conformations of the  
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bacterial orthologue leucine symporter (LeuT) from Aquifex 
aeolicus. Although GABA transporter is functionally active 
as a monomer [4], proper trafficking requires its dimerisation 
providing GABA transporters as dimers or clusters of dimers 
at the cell surface [5]. In order to disclose functional conse-
quences of dimerisation, a homodimeric model of the oc-
cluded hGAT1 was constructed using the LeuT template [2]. 
MATERIALS AND METHODS 
Modeling hGAT1 Homodimer from LeuT Dimeric Crys-
tal Structure 
The model was built by the Modeller 9.10 program [6], 
using the alignment of Beuming et al., [7]. In detail, the di-
meric structure of 2A65 was downloaded from the PDB da-
tabase, and the residues Leu, beta octylglucoside and water 
were cut out from the structure, and the protein chain and the 
four sodium ions (two on each side) were retained. The se-
quence of hGAT1 (SC6A1_HUMAN) was downloaded from 
SwissProt (UniProtKB/Swiss-Prot code: P30531). This se-
quence in duplicate was continuously aligned to chain A and 
chain B of 2A65. The alignment was set manually according 
to Beuming et al., [7]. The position of the two Na+ ions 
Na+(1) and Na+(2) was set to be directly taken from the pdb 
template, to occupy the same position (coordinates) in the 
hGAT1 model as in 2A65. Putative disordered regions of 
hGATs were searched using the IUPRED server [8, 9], 
which revealed none or negligible disorder even in the flexi-
ble EL2 loop, therefore we found it reliable to include it in 
the automated modelling procedure. However, to restrict the 
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number of possible conformations, we took advantage of the 
fact, that the EL2 loop for NSS transporters contains a disul-
fide bond formed between C164 and C173 [10], therefore we 
integrated Modeller’s “DISU patch” (disulfide modelling 
option) into our modelling routine and set these residues to 
form disulfide bonds in both chains. The resulting structure 
from Modeller was obtained in pdb format. Hydrogen atoms 
and MMFF94 charges were put on this model in SYBYL, 
where also acetyl and N-methyl groups were placed on the N 
and C termini. In addition, Cl- ions were added in SYBYL to 
the suggested binding site [11, 12], namely among residues 
Tyr86, Ser295, Asn327 and Ser331. To evaluate molecular 
motions that can be considered specific for cellular uptake of 
GABA, we also built an inward open hGAT1 model based 
on the inward open LeuT variant (pdb code: 3TT3, [3]). In 
contrast to the occluded state LeuT, however, the inward-
facing variant was crystallised as a monomer. Therefore the 
dimeric inward open model was constructed in two steps. 
First, a dimeric template was built by fitting two 3TT3 
monomers on the 2A65 dimer followed by modelling the 
open-to-in conformation of hGAT1 based on this dimeric 
template. Neither Na+ and Cl- ions, nor GABA were included 
during the model building. 
GABA Docking and MD Simulations 
GABA docking to primary site S1 [2, 13-17] in the oc-
cluded conformation of the homodimeric hGAT1 model was 
performed using the GOLD 4.0 docking program (Cam-
bridge Crystallographic Data Centre Software Ltd., Cam-
bridge, UK). Monomers A and B refer to the chain names in 
2A65 dimer. The search space for docking was a 10 Å 
sphere around Na+(1) on each side. GABA docking was re-
peated 10 times and the average of the GOLD scores in 10 
runs was used for further analysis. Docked GABA residues 
were merged to the protein in SYBYL and the structure ob-
tained so far was subjected to molecular dynamics (MD) 
simulations using the CHARMM modelling package [18] in 
a 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) mem-
brane bilayer. In the MD simulations hydrogen atoms were 
automatically generated and the structures were energy 
minimized in a protein only environment in 100 steps steep-
est descent cycles. During the minimization procedure, posi-
tions of heavy atoms were kept in place with a harmonic 
restraining force (first 50 then 10 kcal/mol/Å). Scripts from 
the CHARMM-GUI [19] membrane builder module were 
used for the generation, minimization and preproduction 
equilibration calculations of the hGAT1 in POPC membrane 
bilayer system. The simulation system comprised 154963 
(occluded) and 157649 (inward-facing) atoms consisting of 
hGAT1, GABA, POPC, TIP3 water molecules and sodium, 
potassium and chloride ions. During constant temperature, 
pressure and fixed lipid area MD simulations Langevin pis-
ton algorithm was used to maintain the temperature at 303 K 
and a pressure of 1 atm. The pressure was controlled by the 
Langevin barostat with a piston collision frequency of 20 ps-
1 and the target temperature was kept with the thermal piston 
mass of 2000 kcal*mol-1*ps2. Electrostatic interactions 
were evaluated using the PME method with a grid spacing 
below 1 Å. The bonds between hydrogen and heavy atoms 
were constrained with the SHAKE algorithm. In all simula-
tions the all-atom force field CHARMM22 for the protein 
and CHARMM36 for the lipid atoms [20] were used. The 
integration time-step was 2.0 fs. Figures were generated us-
ing the enhanced perspective option of Pymol. 
MD simulation time was 13.641 ns. The hGAT1 back-
bone atoms RMSD plots during the last 5 ns of the simula-
tion did not show any significant change. For further analy-
sis, structures from the last 1 ns simulation were used. Two 
additional similar MD computations were also performed. In 
the second simulation (run 2) only the initial random number 
used at the initial step of the MD simulation was changed. In 
the third simulation (run 3) the values of the constraining 
force used during the minimization procedure were doubled 
compared to original. 
RESULTS 
Construction of the hGAT1 Homodimer Model 
We modelled the major human GABA transporter sub-
type hGAT1. The occluded conformation of the homologous 
bacterial LeuT homodimeric structure (pdb code: 2A65) was 
used as a template for model building. Since LeuT formed 
dimers in the crystal in the occluded state, this structure can 
be directly used to model hGAT1 in the dimeric state (Fig. 1 
top). To evaluate molecular motions that can be considered 
specific for cellular uptake of GABA, we also built an in-
ward open hGAT1 model based on the inward open LeuT 
variant (pdb code: 3TT3, (3]) (Fig. 1 bottom). The main dif-
ference between the inward-facing and the occluded states of 
the hGAT1 homodimers was the tilted position of the TM1 
helices, similarly to the template LeuT structure [3]. 
 
 
Fig. (1). Overviews of the occluded (top) and apo inward-facing 
(bottom) hGAT1 conformations after 13 ns MD. Top: Occluded 
model, based on the occluded conformation of LeuT (pdb code: 
2a65). Bottom: Apo inward-facing model of hGAT1, based on the 
apo inward-facing structure of LeuT (pdb code: 3TT3).  
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A slightly asymmetrical structure, most pronounced at 
the EL2 loop regions (Fig. 1 top) was obtained for the ho-
modimer hGAT1, which is possibly the consequence of the 
lack of a complete loop in the LeuT template that allows a 
high degree of flexibility in this region. The transmembrane 
parts of the protein, exhibited only subtle differences in side 
chain organization. In contrast to our hGAT1 monomer 
model [13, 14], the OH side chain of Tyr60 points towards 
the S1 binding crevice in the homodimer. It is to note, how-
ever, that the use of different modelling program (Modeller 
[15, 16) instead of Swiss PDB Viewer [13, 14]), can be ac-
counted for the difference.  




After the construction of the hGAT1 homodimer model, 
GABA was docked to the S1 substrate binding crevice. The 
docking was made separately for the two monomer units 
(monomer-A and monomer-B) using the GOLD 4.0 docking 
program. Notably, GABA docked to the S1 substrate binding 
crevices with high docking scores [48-50]. GABA oxygen 
atoms turned towards Na+(1) forming a GABA(O)-Na+(1) 
complex (d = 3 ± 0.2 Å) in both monomers without the need 
to apply any other constraints. The highest scoring GABA 
molecules were then merged to the protein chains and these 
complexes were later used in molecular dynamics (MD) 
runs. Since Tyr60 points to the binding crevice, the docked 
GABA is able to contact its side chain, in line with the mod-
els of Wein and Wanner [15] and Skovstrup et al. [16] (see 
also the previous section). Following GABA docking proce-
dures, the structures obtained so far were subjected to short 
MD simulations using the CHARMM modelling package in 
a POPC membrane bilayer [18-20]. 
We have observed that in MD runs 1 and 3, the 
GABA(O)-Na+(1) complex formed a ring-like structure with 
a characteristic 3 Å CD-N distance of GABA in both mono-
mer-A and monomer-B. To test whether the formation of a 
ring-like GABA is energetically favourable, "in vacuo" Har-
tree-Fock and B3LYP density functional theory calculations 
(6-31G** and 6-311++G** basis sets) were performed by 
using commercial software Gaussian E01 (MO calculations 
were performed with the DFT method at the B3LYP/6-31G* 
level using the Gaussian 03 program package). It was found 
that GABA formed into a ring-like structure even when the 
calculations started from the linear GABA conformation. 
The ring-like GABA structure was further stabilized by the 
addition of Na+(1) ion. In MD run 2 that is basically identical 
to MD run 1 and 3, however, GABA(O)-Na+(1) complex 
showed different conformations in the two monomers, 
namely the ring-like structure in monomer-A and a half-
extended GABA(O)-Na+(1) complex with d(CD-N) = 4.5 Å 
in monomer-B (Fig. 2). Formation of the ring-like Na+(1)-
GABA complex can be characterised by an apparent rate 
constant around 3 x 108 s-1 (Fig. 2]. These findings indicate 
that the occurrence of the ring-like GABA(O)-Na+(1) com-
plex as well as the co-existence of half-extended binding 
[13] and ring-like [14, 16] traversing (21] conformations of 
GABA in the hGAT homodimer are statistically relevant 
events in the hGAT1 homodimer. 
When the structures of hGAT1 monomer-A and mono-
mer-B were compared, one of the MD simulations (run 1) 
showed a striking difference between the overall structures 
of the two monomers. Monomer-A remained in the initial 
occluded state conformation, while monomer-B showed 
large-scale molecular rearrangement including the opening 
of a water-permeable pore that finally arranged a structure 
resembling the inward-facing conformation (c.f. Fig. 1 bot-
tom). These MD data suggest that despite the sequence iden-
tity of monomer-A and monomer-B in the hGAT1 homodi-
mer, asymmetries have evolved between the two monomers 
of the GAT1 homodimer, i.e. the two monomers can poten-
tially behave differently. 
To get insights into the molecular motions underlying 
functional transitions, we analyzed the movements of indi-
vidual residues. We calculated the RMS difference of each 
residue between monomer-A and monomer-B in MD run 1. 
 
Fig. (2). GABA in S1 of hGAT1: (CD) - N distance in MD run 2. 
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Besides the extra- and intracellular loops, the highest RMS 
values were observed for residues in the transmembrane 
helices near the GABA binding crevice (TM1, TM6, TM7 
and TM8), but interestingly, high residue mobility was found 
for TM5 and TM11 that are relatively far from the substrate 
binding site (Fig. 3A). According to their flexible nature, the 
extra- and intracellular loops, especially the highly flexible 
EL2 loop showed prominent movements. The rearrange-
ments, however, also involved the transmembrane helices 
close to the S1 GABA binding site (TM1, TM5, TM6, TM7, 
TM8 and TM11, Fig. 3B). 
Detailed analysis of the structural changes in monomer-B 
revealed functionally essential molecular transitions. GABA 
in monomer-B lost its coordination to Na+(1), instead, it par-
ticipated in H-bonding with two water molecules that were 
penetrated into the binding cavity during MD (Fig. 4). Con-
currently, Na+(1) formed salt bridge with bound Cl- ion. 
Na+(1) ion was coordinated by residues from TM1 (Ala61, 
Asn66), TM6 (Ser295) at start, and gained another coordi-
nating residue from TM7 (Asn327) after 13 ns. Most impor-
tantly, the salt bridge formation with bound Cl- ion pulled 
Na+(1) away from GABA concurrently. Na+(2) was coordi-
nated by less residues after 13 ns MD collecting a water 
molecule into its binding crevice (Fig. 5). These energeti-
cally favourable changes shape monomer-B in a conforma-
tion clearly different from monomer-A, also characterised by 
the unbinding tendency of Na+(2) in monomer-B (Fig. 4). In 
monomer-A, however, GABA remained in complex with 
Na+(1) ion, i.e. Cl- ion did not interact with Na+(1) ion after 
MD simulation. In addition, neither GABA nor Na+(2) ion 
became hydrated (data not shown). These binding interac-
tions are similar to those observed in the occluded conforma-
tion [2], supporting that monomer-A mimics the occluded 
state.  
DISCUSSION 
Temporal analysis of global residue movements through-
out the MD simulation has shown that the molecular rear-
rangement of the transporter was initiated at the extracellular 
surface mostly involving helices implicated in GABA, 
Na+(1) and Cl- binding TM1, TM6, TM7 and TM11 [21] 
(Fig. 3). Eventually, these movements were conducted 
through the transmembrane helices to the intracellular side. 
Importantly, after approximately 4-6 ns, the TM8 became 
involved in the molecular restructuring also initiating its 
movement at the extracellular surface. The involvement of 
TM8 might be of paramount importance, because its residues 
are associated to GABA and Na+(2) binding and also to the 
formation of intracellular gate [21] and the water penetration 
pathway, through which water accesses GABA and Na+ ions 
to get them hydrated (Fig. 5). Local events occurring in bind-
ing crevices of the homodimer disclosed that the two mono-
mers may undergo different fluctuations, resulting in distin-
guishable conformations allowing traverse of GABA in one 
of the monomers (Fig. 6). GABA prefers the H-bridged ring-
like (traversing) conformation in complex with Na+(1), al-
though either half-extended or Na+(1) released conforma-
tions possibly co-exist in the two monomers. H-bridged ring-
like GABA coordinates Na+(1) in monomer-A, while in 
monomer-B, it is hydrated by water molecules (Fig. 6). 
 
Fig. (3). Details of asymmetric structural changes during MD run 1. A: Time dependence of RMS difference between residues of monomer-
A and monomer-B. Each row represents an individual residue. The color bar represents the extent of RMS difference of the same residue 
between the two monomers. B: 3D representation of the structural movement by assigning each RMS values to the corresponding residue 
in the hGAT1 model at different times. Helices near the GABA binding crevice (TM1, TM6, TM7 and TM8) are shown as cartoons. The 
color bar represents the extent of RMS difference of the same residue between the two monomers. 
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Fig. (4). Binding interactions of GABA, Na+(1) and Na+(2) ions characterize pre-inward open conformation of monomer-B. GABA (left), 
Na+(1) (middle) and Na+(2) (right) in the occluded hGAT1 homodimer at the start of the simulation (gray) and after 13 ns MD (orange) simu-
lation. Color code: GABA–dark gray, black, Na+ ions–purple, Cl- ion–green. 
 
 
Fig. (5). Penetration of water molecules into the binding crevice. A: Water molecules freely penetrate into the binding crevices of both inward 
open hGAT1 monomer-A (left) and monomer-B (right). B: Water molecules appear after 13 ns MD simulation in the occluded state model 
within 5Å. GABA binding crevice residues within 4Å and the Cl- ion are shown. 
 
In the same run, Na+ ions are found in a more polar envi-
ronment bridging Cl- ion (Na+(1)) and water (Na+(2))  
(Fig. 6). The asymmetric fluctuations observed in one of the 
MD simulations of the occluded state hGAT1 homodimer 
model, therefore, may provide useful information to better 
understand the mechanistic clues underlying substrate trav-
erse through NSSs also featuring the LeuT-fold symmetry 
and a break in TM1 and TM6 helices forming Na+/solute 
binding crevice, like hGAT1 does.  
We found structural fluctuations distinguishing mono-
mers by short-term MD simulations of the occluded hGAT1 
homodimer. Notably, water was able to penetrate into the 
binding crevice only in monomer-B, but not in monomer-A. 
In monomer-B water appeared next to GABA and Na+(2), 
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Fig. (6). Early rearrangements persistent in binding crevices of the hGAT1 homodimer can be considered critical in terms of GABA traverse. 
From left to right: formation of major H-bridged GABA structure assisted by Na+(1), hydration of GABA; translocation of Na+(1) to Asn-
327-bound Cl- ion, appearance of water at the Na+(2) binding site. 
 
like in the inward-facing homodimer model (Fig. 1 bottom). 
Being persistent in the nanosecond range of time, statistical 
time events in the membrane symporter such as helix-coil 
transitions collecting solute binding, intramolecular hydro-
gen bonding, hydration and charge translocation [22] may 
spread throughout the monomer-B towards the intracellular 
membrane face similarly to the opening of the acetylcholine 
receptor channel [23]. In this way, monomer-B is ready to 
transit to the inward-facing state, therefore the structural 
fluctuations may be considered as functional, representing an 
intermediate state during the solute translocation process. 
Thus, the initial LeuT-fold asymmetry of the occluded state 
monomer, furthering in the homodimer after short MD may 
be indicative of forthcoming inward substrate release by 
hGAT1. We conjecture substrate/ligand-induced asymmetry 
of membrane protein oligomers including NSSs (this work) 
or ligand-gated ion channel subtypes [23–27] as a structural 
prerequisite for facilitating symport, channel opening or de-
sensitisation. 
In support of the notion that the lifetime of the traversing 
conformation that was modelled is in the order of nanosec-
onds we refer to data collected in Table 1. Plotting of 
log(kapp) vs. log(sampling time) reveals linear correlation 
(R2=0.95) indicating that the apparent rate constant obtained 
from macroscopic GABA uptake data scales right down to 
the microscopic elementary steps, such as the formation of 
traversing conformation of GABA described in the 1-10 ns 
range of time. It is to note, that opening of ionic channels 
also acts upon scaling dynamics [33].  
 
Table 1.  Apparent rate constant for GABA uptake correlates 
the sampling time of techniques applied. 
Sampling Time (s) kapp (s-1) References 
10-11 3 x 108 this work 
2x 10-10 107 28 
2x 10-10 7x106 17 
4x10-5 3x102 29 
8x10-5 70 30 
10-4 10 31 
10 5.4x10-2 32 
100 4.44 10-3 32 
 
CONCLUSION 
It appears likely that time events appearing within the 
simulation time chosen in the homodimer of neuronal 
hGAT1 subtype reflect mechanistically relevant molecular 
events underlying complex kinetics of GABA-sodium sym-
port [29 and references cited, 30-32, 34]. We extend our 
findings to astroglial hGAT2 and hGAT3 subtypes in par-
ticular and NSSs homodimers in general. Thus, deeper in-
sights into binding/transport phenomena of NSS oligomers 
through coarse-grain simulation of the whole alternating 
access transport cycle in the future may open up new ave-
nues in NSS-based CNS drug design and discovery [1, 21, 
35, 36 and reference cited].  
ABBREVIATIONS 
CNS = Central nervous system 
EL2 = Extracellular loop 2 
GABA = -aminobutyric acid, the major inhibitory neu-
rotransmitter in the brain 
GAT = -aminobutyric acid transporter 
hGAT1 = Neuronal human GABA transporter subtype 1 
hGAT2 = Astroglial human GABA transporter subtype 2  
hGAT3 = Astroglial human GABA transporter subtype 3 
LeuT = Leucine transporter 
MD = Molecular dynamics 
NSS = Neurotransmitter sodium symporter 
SLC = Solute carrier 
TM = Transmembrane helix 
RMS = Root main square 
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